Report Detail

Request for Sample of this report

Service & Software Global AI Drug Safety Prediction Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4724891
    • |
  • 03 August, 2026
    • |
  • Global
    • |
  • 115 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global AI Drug Safety Prediction Software market size was valued at US$ 422 million in 2025 and is forecast to a readjusted size of US$ 1735 million by 2032 with a CAGR of 22.5% during review period.
AI drug safety prediction software uses machine learning, deep learning, QSAR, expert rules, and physics-based models to predict absorption, distribution, metabolism, excretion, toxicity, drug-drug interactions, off-target effects, and safety pharmacology risks from molecular structures, experimental data, and curated knowledge bases. Typical functions include batch screening, applicability-domain and confidence assessment, explainability, custom model training, API or private deployment, and regulatory-ready reporting for drug discovery, preclinical research, and safety decision-making. The average gross margin is approximately 75%.
Demand mainly comes from pharmaceutical companies, biotechnology firms, CROs, and research institutions that are moving safety-risk screening earlier in development. The high cost of terminating candidates at later stages because of toxicity, pharmacokinetic, or drug-interaction liabilities encourages the use of computational prediction during hit screening, lead optimization, and candidate selection. Efforts to reduce animal testing, the expansion of virtual compound libraries, and broader regulatory use of new approach methodologies also support software adoption.
Product development is shifting from isolated QSAR endpoints toward combinations of multitask deep learning, expert knowledge, and physics-based simulation, with greater emphasis on applicability domains, confidence estimates, structural alerts, and analogue evidence. Established vendors retain advantages through curated toxicology databases, validated models, and regulatory workflows, while AI-native platforms are gaining adoption through faster computation, frequent model updates, and closed design-prediction loops. Purchasing decisions typically focus on endpoint coverage, external validation, proprietary-data model building, deployment security, system integration, and reporting compliance.
North America and Europe remain the leading commercial markets, while China and other Asian markets have strong potential because of expanding innovative-drug investment, local AI drug-discovery companies, and demand for private deployment. Opportunities include localization for regulatory requirements, enterprise-specific model training, multimodal safety assessment, and integration with experimental platforms. Key risks are training-data bias, unreliable predictions outside the applicability domain, limited coverage of biologics, and the continuing need for experimental confirmation and expert review.
Report Scope
This report is a detailed and comprehensive analysis for global AI Drug Safety Prediction Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Drug Safety Prediction Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Drug Safety Prediction Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Drug Safety Prediction Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Simulations Plus, Dassault Systèmes, Schrödinger, Certara, Lhasa Limited, Instem, ACD/Labs, Chemical Computing Group, Optibrium, MultiCASE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Drug Safety Prediction Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Integrated ADMET Prediction
Toxicity Endpoint Prediction
Drug-Drug Interaction and PK Safety Prediction
Metabolism and Metabolite Prediction
Off-Target and Safety Pharmacology Prediction
Market segment by Deployment Model
Cloud-Based
On-Premises
Hybrid Deployment
Market segment by Modeling Approach
Machine Learning and Deep Learning
QSAR and Statistical Modeling
Knowledge-Based and Rule-Based
Physics-Based Simulation
Hybrid Modeling
Market segment by Model Customization
Fixed Pretrained Models
User-Trained Models
Hybrid Model Platforms
Market segment by Application
Hit and Lead Screening
Lead Optimization
Candidate Selection
Preclinical Safety Assessment
Regulatory Safety Assessment
Other Drug Safety Research
Market segment by players, this report covers
Simulations Plus
Dassault Systèmes
Schrödinger
Certara
Lhasa Limited
Instem
ACD/Labs
Chemical Computing Group
Optibrium
MultiCASE
Insilico Medicine
MindRank
Molecular Discovery
Molecular Networks
OASIS LMC
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe AI Drug Safety Prediction Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Drug Safety Prediction Software, with revenue, gross margin, and global market share of AI Drug Safety Prediction Software from 2021 to 2026.
Chapter 3, the AI Drug Safety Prediction Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Drug Safety Prediction Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Safety Prediction Software.
Chapter 13, to describe AI Drug Safety Prediction Software research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Drug Safety Prediction Software by Type
    • 1.3.1 Overview: Global AI Drug Safety Prediction Software Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Type in 2025
    • 1.3.3 Integrated ADMET Prediction
    • 1.3.4 Toxicity Endpoint Prediction
    • 1.3.5 Drug-Drug Interaction and PK Safety Prediction
    • 1.3.6 Metabolism and Metabolite Prediction
    • 1.3.7 Off-Target and Safety Pharmacology Prediction
  • 1.4 Classification of AI Drug Safety Prediction Software by Deployment Model
    • 1.4.1 Overview: Global AI Drug Safety Prediction Software Market Size by Deployment Model: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Deployment Model in 2025
    • 1.4.3 Cloud-Based
    • 1.4.4 On-Premises
    • 1.4.5 Hybrid Deployment
  • 1.5 Classification of AI Drug Safety Prediction Software by Modeling Approach
    • 1.5.1 Overview: Global AI Drug Safety Prediction Software Market Size by Modeling Approach: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Modeling Approach in 2025
    • 1.5.3 Machine Learning and Deep Learning
    • 1.5.4 QSAR and Statistical Modeling
    • 1.5.5 Knowledge-Based and Rule-Based
    • 1.5.6 Physics-Based Simulation
    • 1.5.7 Hybrid Modeling
  • 1.6 Classification of AI Drug Safety Prediction Software by Model Customization
    • 1.6.1 Overview: Global AI Drug Safety Prediction Software Market Size by Model Customization: 2021 Versus 2025 Versus 2032
    • 1.6.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Model Customization in 2025
    • 1.6.3 Fixed Pretrained Models
    • 1.6.4 User-Trained Models
    • 1.6.5 Hybrid Model Platforms
  • 1.7 Global AI Drug Safety Prediction Software Market by Application
    • 1.7.1 Overview: Global AI Drug Safety Prediction Software Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Hit and Lead Screening
    • 1.7.3 Lead Optimization
    • 1.7.4 Candidate Selection
    • 1.7.5 Preclinical Safety Assessment
    • 1.7.6 Regulatory Safety Assessment
    • 1.7.7 Other Drug Safety Research
  • 1.8 Global AI Drug Safety Prediction Software Market Size & Forecast
  • 1.9 Global AI Drug Safety Prediction Software Market Size and Forecast by Region
    • 1.9.1 Global AI Drug Safety Prediction Software Market Size by Region: 2021 VS 2025 VS 2032
    • 1.9.2 Global AI Drug Safety Prediction Software Market Size by Region, (2021-2032)
    • 1.9.3 North America AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
    • 1.9.4 Europe AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
    • 1.9.5 Asia-Pacific AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
    • 1.9.6 South America AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
    • 1.9.7 Middle East & Africa AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Simulations Plus
    • 2.1.1 Simulations Plus Details
    • 2.1.2 Simulations Plus Major Business
    • 2.1.3 Simulations Plus AI Drug Safety Prediction Software Product and Solutions
    • 2.1.4 Simulations Plus AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Simulations Plus Recent Developments and Future Plans
  • 2.2 Dassault Systèmes
    • 2.2.1 Dassault Systèmes Details
    • 2.2.2 Dassault Systèmes Major Business
    • 2.2.3 Dassault Systèmes AI Drug Safety Prediction Software Product and Solutions
    • 2.2.4 Dassault Systèmes AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Dassault Systèmes Recent Developments and Future Plans
  • 2.3 Schrödinger
    • 2.3.1 Schrödinger Details
    • 2.3.2 Schrödinger Major Business
    • 2.3.3 Schrödinger AI Drug Safety Prediction Software Product and Solutions
    • 2.3.4 Schrödinger AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Schrödinger Recent Developments and Future Plans
  • 2.4 Certara
    • 2.4.1 Certara Details
    • 2.4.2 Certara Major Business
    • 2.4.3 Certara AI Drug Safety Prediction Software Product and Solutions
    • 2.4.4 Certara AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Certara Recent Developments and Future Plans
  • 2.5 Lhasa Limited
    • 2.5.1 Lhasa Limited Details
    • 2.5.2 Lhasa Limited Major Business
    • 2.5.3 Lhasa Limited AI Drug Safety Prediction Software Product and Solutions
    • 2.5.4 Lhasa Limited AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Lhasa Limited Recent Developments and Future Plans
  • 2.6 Instem
    • 2.6.1 Instem Details
    • 2.6.2 Instem Major Business
    • 2.6.3 Instem AI Drug Safety Prediction Software Product and Solutions
    • 2.6.4 Instem AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Instem Recent Developments and Future Plans
  • 2.7 ACD/Labs
    • 2.7.1 ACD/Labs Details
    • 2.7.2 ACD/Labs Major Business
    • 2.7.3 ACD/Labs AI Drug Safety Prediction Software Product and Solutions
    • 2.7.4 ACD/Labs AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ACD/Labs Recent Developments and Future Plans
  • 2.8 Chemical Computing Group
    • 2.8.1 Chemical Computing Group Details
    • 2.8.2 Chemical Computing Group Major Business
    • 2.8.3 Chemical Computing Group AI Drug Safety Prediction Software Product and Solutions
    • 2.8.4 Chemical Computing Group AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Chemical Computing Group Recent Developments and Future Plans
  • 2.9 Optibrium
    • 2.9.1 Optibrium Details
    • 2.9.2 Optibrium Major Business
    • 2.9.3 Optibrium AI Drug Safety Prediction Software Product and Solutions
    • 2.9.4 Optibrium AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Optibrium Recent Developments and Future Plans
  • 2.10 MultiCASE
    • 2.10.1 MultiCASE Details
    • 2.10.2 MultiCASE Major Business
    • 2.10.3 MultiCASE AI Drug Safety Prediction Software Product and Solutions
    • 2.10.4 MultiCASE AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 MultiCASE Recent Developments and Future Plans
  • 2.11 Insilico Medicine
    • 2.11.1 Insilico Medicine Details
    • 2.11.2 Insilico Medicine Major Business
    • 2.11.3 Insilico Medicine AI Drug Safety Prediction Software Product and Solutions
    • 2.11.4 Insilico Medicine AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Insilico Medicine Recent Developments and Future Plans
  • 2.12 MindRank
    • 2.12.1 MindRank Details
    • 2.12.2 MindRank Major Business
    • 2.12.3 MindRank AI Drug Safety Prediction Software Product and Solutions
    • 2.12.4 MindRank AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 MindRank Recent Developments and Future Plans
  • 2.13 Molecular Discovery
    • 2.13.1 Molecular Discovery Details
    • 2.13.2 Molecular Discovery Major Business
    • 2.13.3 Molecular Discovery AI Drug Safety Prediction Software Product and Solutions
    • 2.13.4 Molecular Discovery AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Molecular Discovery Recent Developments and Future Plans
  • 2.14 Molecular Networks
    • 2.14.1 Molecular Networks Details
    • 2.14.2 Molecular Networks Major Business
    • 2.14.3 Molecular Networks AI Drug Safety Prediction Software Product and Solutions
    • 2.14.4 Molecular Networks AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Molecular Networks Recent Developments and Future Plans
  • 2.15 OASIS LMC
    • 2.15.1 OASIS LMC Details
    • 2.15.2 OASIS LMC Major Business
    • 2.15.3 OASIS LMC AI Drug Safety Prediction Software Product and Solutions
    • 2.15.4 OASIS LMC AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 OASIS LMC Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Drug Safety Prediction Software Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of AI Drug Safety Prediction Software by Company Revenue
    • 3.2.2 Top 3 AI Drug Safety Prediction Software Players Market Share in 2025
    • 3.2.3 Top 6 AI Drug Safety Prediction Software Players Market Share in 2025
  • 3.3 AI Drug Safety Prediction Software Market: Overall Company Footprint Analysis
    • 3.3.1 AI Drug Safety Prediction Software Market: Region Footprint
    • 3.3.2 AI Drug Safety Prediction Software Market: Company Product Type Footprint
    • 3.3.3 AI Drug Safety Prediction Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Drug Safety Prediction Software Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global AI Drug Safety Prediction Software Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global AI Drug Safety Prediction Software Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
  • 6.2 North America AI Drug Safety Prediction Software Market Size by Application (2021-2032)
  • 6.3 North America AI Drug Safety Prediction Software Market Size by Country
    • 6.3.1 North America AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
    • 6.3.2 United States AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 6.3.3 Canada AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
  • 7.2 Europe AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
  • 7.3 Europe AI Drug Safety Prediction Software Market Size by Country
    • 7.3.1 Europe AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
    • 7.3.2 Germany AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 7.3.3 France AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 7.3.5 Russia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 7.3.6 Italy AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific AI Drug Safety Prediction Software Market Size by Region
    • 8.3.1 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Region (2021-2032)
    • 8.3.2 China AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 8.3.3 Japan AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 8.3.5 India AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 8.3.7 Australia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
  • 9.2 South America AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
  • 9.3 South America AI Drug Safety Prediction Software Market Size by Country
    • 9.3.1 South America AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa AI Drug Safety Prediction Software Market Size by Country
    • 10.3.1 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
    • 10.3.4 UAE AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 AI Drug Safety Prediction Software Market Drivers
  • 11.2 AI Drug Safety Prediction Software Market Restraints
  • 11.3 AI Drug Safety Prediction Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Drug Safety Prediction Software Industry Chain
  • 12.2 AI Drug Safety Prediction Software Upstream Analysis
  • 12.3 AI Drug Safety Prediction Software Midstream Analysis
  • 12.4 AI Drug Safety Prediction Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI Drug Safety Prediction Software. Industry analysis & Market Report on AI Drug Safety Prediction Software is a syndicated market report, published as Global AI Drug Safety Prediction Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI Drug Safety Prediction Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo